Department of Imaging, Massachusetts General Hospital, Boston, MA 02114, USA.
Cardiovasc Intervent Radiol. 2012 Oct;35(5):1053-8. doi: 10.1007/s00270-011-0247-2. Epub 2011 Aug 17.
A rare but described risk factor for deep venous thrombosis (DVT), predominantly in the young, is congenital agenesis or atresia of the inferior vena cava (IVC). The optimal management for DVT in this subset of patients is unknown. We evaluated the efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) followed by systemic anticoagulation in the treatment of acute lower-extremity DVT in the setting of congenital IVC agenesis or atresia.
Between November of 2005 and May of 2010, six patients (three women [average age 21 years]) were referred to our department with acute lower-extremity DVT and subsequently found to have IVC agenesis or atresia on magnetic resonance imaging. A standardized technique for PCDT (the Angiojet Rheolytic Thrombectomy System followed by the EKOS Microsonic Accelerated Thrombolysis System) was used for all subjects. Successful thrombolysis was followed by systemic heparinization with transition to Coumadin or low molecular-weight heparin and compression stockings. Subjects were followed-up at 1, 3, and then every 6 months after the procedure with clinical assessment and bilateral lower-extremity venous ultrasound.
All PCDT procedures were technically successful. No venous stenting or angioplasty was performed. The average thrombolysis time was 28.6 h (range 12-72). Two patients experienced heparin-induced thrombocytopenia, and one patient developed a self-limited knee hemarthrosis, No patients were lost to follow-up. The average length of follow-up was 25.8 ± 20.2 months (range 3.8-54.8). No incidence of recurrent DVT was identified. There were no manifestations of postthrombotic syndrome.
PCDT followed by systemic anticoagulation and the use of compression stockings appears to be safe and effective in relatively long-term follow-up treatment of patients who present with acute DVT and IVC agenesis or atresia.
深静脉血栓形成(DVT)的一个罕见但已被描述的危险因素主要发生在年轻人中,即下腔静脉(IVC)先天缺失或闭锁。对于这部分患者,DVT 的最佳治疗方法尚不清楚。我们评估了药物机械性导管溶栓(PCDT)联合全身抗凝治疗急性下肢 DVT 的疗效,该方法适用于伴有 IVC 先天缺失或闭锁的患者。
2005 年 11 月至 2010 年 5 月,6 例(3 例女性[平均年龄 21 岁])患者因急性下肢 DVT 就诊,随后在磁共振成像检查中发现 IVC 缺失或闭锁。所有患者均采用标准化的 PCDT 技术(Angiojet 旋切血栓切除术系统联合 EKOS 微声加速溶栓系统)。所有患者均成功溶栓后接受全身肝素化治疗,随后过渡到华法林或低分子肝素和加压弹力袜。所有患者在术后 1、3 个月和此后每 6 个月进行临床评估和双侧下肢静脉超声检查。
所有 PCDT 操作均成功完成。无静脉支架或血管成形术。平均溶栓时间为 28.6 小时(范围 12-72 小时)。2 例患者发生肝素诱导的血小板减少症,1 例患者发生自限性膝关节积血。无患者失访。平均随访时间为 25.8±20.2 个月(范围 3.8-54.8 个月)。未发现复发性 DVT。无血栓后综合征的表现。
PCDT 联合全身抗凝和使用加压弹力袜的治疗方法在长期随访中对伴有急性 DVT 和 IVC 缺失或闭锁的患者似乎是安全有效的。